KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Amortization of Deferred Charges (2018 - 2020)

Castle Biosciences (CSTL) has disclosed Amortization of Deferred Charges for 3 consecutive years, with $173000.0 as the latest value for Q4 2020.

  • Quarterly Amortization of Deferred Charges fell 26.07% to $173000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $173000.0 through Sep 2021, down 80.78% year-over-year, with the annual reading at $839000.0 for FY2020, 56.42% down from the prior year.
  • Amortization of Deferred Charges hit $173000.0 in Q4 2020 for Castle Biosciences, down from $214000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $767000.0 in Q2 2019 to a low of $139273.0 in Q3 2018.
  • Historically, Amortization of Deferred Charges has averaged $269820.2 across 3 years, with a median of $226000.0 in 2020.
  • Biggest five-year swings in Amortization of Deferred Charges: surged 75.91% in 2019 and later tumbled 70.27% in 2020.
  • Year by year, Amortization of Deferred Charges stood at $139929.0 in 2018, then surged by 67.23% to $234000.0 in 2019, then dropped by 26.07% to $173000.0 in 2020.
  • Business Quant data shows Amortization of Deferred Charges for CSTL at $173000.0 in Q4 2020, $214000.0 in Q3 2020, and $228000.0 in Q2 2020.